Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

Autor: Gold, Michael, Lambiase, Pier, El-Chami, Mikhael, Knops, Reinoud, Aasbo, Johan, Bongiorni, Maria Grazia, Russo, Andrea, Deharo, Jean-Claude, Burke, Martin, Dinerman, Jay, Barr, Craig, Shaik, Naushad, Carter, Nathan, Stoltz, Thomas, Stein, Kenneth, Brisben, Amy, Boersma, Lucas, Boersma, Lucas V.A., Phelan, Timothy, Al-Ameri, Hazim, Albirini, Abdulhay, Alimohammad, Rizwan, Arias, Miguel, Badenco, Nicolas, Bertaux, Geraldine, Bhakta, Deepak, Bindra, Sanjay, Blangy, Hugues, Boveda, Serge, Brock, Johansen, Busch, Mathias, Calvo, Naiara, Cassidy, Christopher, Chauvin, Michel, Marzak, Halim, Chinitz, Jason, Ciuffo, Allen, Clancy, Jude, Crossen, Karl, de Filippo, Paolo, Devecchi, Fausto, Karanam, Sreekanth, Doshi, Rahul, Eckardt, Lars, Fedor, Matthew, Freedman, Roger, Gehi, Anil, Goethals, Peter, Gosau, Nils, Gottlieb, Charles, Granrud, Gregory, Greenstein, Radmira, Hamdan, Firas, Hanon, Sam, Hassankhani, Alborz, Henderson, Rick, Hohnloser, Stefan, Huang, David, Irles, Didier, Kalahasty, Gautham, Kazemian, Pedram, Khairallah, Farhat, Kim, Brian, Kim, Edward, Klein, Christoph, Knight, Bradley, Koide, Niuton, Kuk, Richard, Leclercq, Christophe, Lee, Michael, Lee, Shang-Chiun, Lenz, Corinna, Lewis, Nigel, Lewis, Robert, Mark, George, Marquie, Christelle, Mcdonnell, Kelly, Mckenzie, John, Merchant, Faisal, Mobarek, Sameh, Moccetti, Tiziano, Molin, Franck, Philliopon, Francois, Morani, Giovanni, Morin, Daniel, Ng, G., Nsah, Emmanuel, Panday, Manoj, Pasquie, Jean-Luc, Castellano Perez, Nicasio, Perez-Gil, Francisco, Ptaszynski, Pawel, Rajendra, Anil, Rhodes, Troy, Roberts, Paul, Rowe, Steven, Saba, Samir, Sagi, Venkata, Sarter, Brian, Schoenhard, John, Schutzman, John, Scott, Luis, Segerson, Nathan, Shakir, Ali, Smelley, Matthew, Steffel, Jan, Sturdivant, J. Lacy, Tabbal, Ghiyath, Tendler, Drory, Theuns, Dominic, Timmers, Liesbeth, Trojan, Matthew, Tsai, Shane, Upadhyay, Gaurav, Varkey, Santosh, Viani, Stefano, Weiner, Stanislav, Weiss, Raul, Wiggins, Sherman, Wright, David, Zadeh, Andrew, Zitron, Edgar

Publikováno v: Circulation, 143(1):048728, 7-17. Lippincott Williams and Wilkins
Circulation
Circulation, 2021, 143 (1), pp.7-17. ⟨10.1161/CIRCULATIONAHA.120.048728⟩

Background: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, had less left ventricular dysfunction, and r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640abb6440c3f63cca2ea2246c19cb3f
https://pure.amc.nl/en/publications/primary-results-from-the-understanding-outcomes-with-the-sicd-in-primary-prevention-patients-with-low-ejection-fraction-untouched-trial(9f644dff-9061-4248-8b93-d46338e7fc12).html

The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients

Autor: Dominique Babuty, Delphine Plassard-Kerdoncuf, Gilles Lande, Christine Fruchet, Vincent Probst, Hervé Le Marec, Frederic Sacher, Béatrice Guyomarch, Philippe Mabo, Jacques Mansourati

Publikováno v: EP-Europace
EP-Europace, Oxford University Press (OUP): Policy B, 2011, 13 (7), pp.1034-9. ⟨10.1093/europace/eur060⟩
EP-Europace, 2011, 13 (7), pp.1034-9. ⟨10.1093/europace/eur060⟩

International audience; AIMS: Brugada syndrome (BrS) is a hereditary arrhythmic disease, responsible for sudden death in patients without known heart disease. An implantable cardioverter defibrillator (ICD) is recommended in patients at high risk of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f6f67429776abb4f65997081f58586
https://doi.org/10.1093/europace/eur060

To the Editor— Diabetes and sudden death: Let’s assess the absolute risk increase rather than the proportional risk from sudden cardiac death!

Autor: João Pedro Ferreira, Faiez Zannad, Giuseppe Ambrosio, Stefano Coiro, Nicolas Girerd

Publikováno v: Heart Rhythm
Heart Rhythm, Elsevier, 2015, 12 (11), pp.e138. ⟨10.1016/j.hrthm.2015.08.008⟩

Shadman et al reported important results evaluating variables associated with the proportion of long-term risk attributable to sudden death (SD) vs non-sudden death (NSD) in patients with heart failure. The authors evaluated those associations using

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05616fdec1ca7fdf7617249bdf63924
https://hal.univ-lorraine.fr/hal-01758773

Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices

Autor: David Gordon, Emilio Bouza, Víctor José González Ramallo, Christine Selton-Suty, Francesc Marco, Eugene Athan, Emanuele Durante-Mangoni, Anna Lisa Chamis, Zainab Samad, Nuria Fernández-Hidalgo, Carlos Cervera, Jorge Solis, Corentine ALAUZET, François Alla, Sarah Israel, Hussien Rizk, Patricia Carmen Muñoz García, Andrew Wang, Juan M Pericas, Souha Kanj, Carlos Falces, Pierre-Edouard Fournier, Assoc Prof Margaret J Henry, Asunción Moreno Camacho, Martin Stryjewski, Antonio Toniolo, Didier Raoult

Publikováno v: Journal of the American Medical Association
Journal of the American Medical Association, American Medical Association (AMA), 2012, 307 (16), pp.1727-35. 〈10.1001/jama.2012.497〉
Journal of the American Medical Association, 2012, 307 (16), pp.1727-35. ⟨10.1001/jama.2012.497⟩
Journal of the American Medical Association, American Medical Association (AMA), 2012, 307 (16), pp.1727-35. ⟨10.1001/jama.2012.497⟩

International audience; CONTEXT: Infection of implantable cardiac devices is an emerging disease with significant morbidity, mortality, and health care costs. OBJECTIVES: To describe the clinical characteristics and outcome of cardiac device infectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::119e978f036d2f59feec228eb9152756
https://hal.archives-ouvertes.fr/hal-00825452

Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study

Autor: Nicolas Lellouche, Eloi Marijon, Didier Klug, Jean-Claude Deharo, Jacques Mansourati, Fabrice Extramiana, Pascal Defaye, Gilles Chatellier, Thomas Lavergne, Jean Marc Davy, Philippe Maury, Jean-Yves Le Heuzey, Michel Chauvin, Hassan Mansour, Xavier Jouven, Vincent Probst, Nicolas Sadoul, Laurent Fauchier, Akli Otmani, Pierre Bordachar, Philippe Chevalier, Christophe Leclercq, Françoise Hidden-Lucet, Frédéric Anselme, Ludovic Trinquart

Publikováno v: American Heart Journal
American Heart Journal, Elsevier, 2010, 159 (4), pp.659-664.e1. ⟨10.1016/j.ahj.2010.01.011⟩
American Heart Journal, 2010, 159 (4), pp.659-664.e1. ⟨10.1016/j.ahj.2010.01.011⟩
American Heart Journal, Elsevier, 2010, 159 (4), pp.659-664.e1. 〈10.1016/j.ahj.2010.01.011〉

International audience; BACKGROUND: Sudden cardiac death (SCD) is the predominant cause of mortality in patients with mild heart failure (HF). This 2-year follow-up, multicenter, cohort study aimed to assess the extent to which implantable cardiovert

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9218f50a69f2e779832570e1f09b5d2
https://hal.univ-brest.fr/hal-00750424